Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000228722 | SCV000284793 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020757 | SCV002751099 | uncertain significance | Nephrolithiasis/nephrocalcinosis | 2024-10-24 | criteria provided, single submitter | clinical testing | The p.Q957R variant (also known as c.2870A>G), located in coding exon 6 of the CASR gene, results from an A to G substitution at nucleotide position 2870. The glutamine at codon 957 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003144170 | SCV003829252 | uncertain significance | not provided | 2022-06-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005031810 | SCV005657442 | uncertain significance | Familial hypocalciuric hypercalcemia 1; Neonatal severe primary hyperparathyroidism; Epilepsy, idiopathic generalized, susceptibility to, 8; Autosomal dominant hypocalcemia 1 | 2024-05-24 | criteria provided, single submitter | clinical testing |